drugset
drugset / Trial / NCT04357600

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B

NCT04357600 ↗

Phase 1/2 Enrolling by invitation 12 enrolled PT. Prodia Stem Cell Indonesia
NaSingle-groupOpen-labelTreatment

Summary

The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.

Timeline

Start
2018-05-17
Primary completion
2027-06-20
Completion
2028-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject ProSTEM Cell therapy 1e+08 cells Intravenous

Indications

cirrhosis of liver